Essex Woodlands Management, Inc. - Q3 2022 holdings

$242 Million is the total value of Essex Woodlands Management, Inc.'s 7 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 22.2% .

 Value Shares↓ Weighting
BVS  BIOVENTUS$84,677,000
+2.6%
12,096,7020.0%34.99%
+2.6%
MDXG  MIMEDX GROUP, INC.$67,203,000
-17.3%
23,415,5840.0%27.77%
-17.3%
TELA BuyTELA BIO, INC.$35,023,000
+40.1%
4,110,709
+15.3%
14.47%
+40.1%
EYPT  EYEPOINT PHARMACEUTICALS INC$33,150,000
+0.5%
4,190,9210.0%13.70%
+0.5%
RVNC  REVANCE THERAPEUTICS INC$12,341,000
+95.4%
457,0850.0%5.10%
+95.3%
VERO  VENUS CONCEPT, INC.$7,189,000
-4.3%
21,169,4570.0%2.97%
-4.3%
MNOV  MEDICINOVA INC$2,400,000
-14.2%
1,105,9410.0%0.99%
-14.3%
CBIO ExitCATALYST BIOSCIENCES INC$0-78,622
-100.0%
-0.06%
ExitSONENDO INC$0-1,992,526
-100.0%
-1.42%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MEDICINOVA INC42Q3 20236.5%
REVANCE THERAPEUTICS INC39Q3 202344.6%
AXOGEN INC26Q4 202143.3%
ENDOLOGIX INC24Q1 201922.5%
ABIOMED INC20Q1 201852.1%
CORIUM INTL INC20Q1 201923.5%
TELA BIO, INC.16Q3 202331.5%
VENUS CONCEPT, INC.16Q3 202321.3%
ACURA PHARMACEUTICALS INC15Q1 20191.4%
CATALYST BIOSCIENCES INC15Q1 20191.0%

View Essex Woodlands Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Essex Woodlands Management, Inc.'s complete filings history.

Compare quarters

Export Essex Woodlands Management, Inc.'s holdings